Skip to content

Aeon Global Health Corp.

Delisted

CIK 885074fmd_158YRMK38VE1NB65E9N024QX7JServices · Services-Medical LaboratoriesTemplate: Standard

Coverage: Jul 01, 2009 to Jun 30, 2019, 37 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019
Total revenues233562435201613
Cost of revenue2233447455
Net interest income––––––(0)(0)(0)(0)
Gross profit01112202816118
Research and development1111100–––
Selling, general and administrative76677919141010
Total operating expenses11101112131429–––
Operating income(9)(7)(8)(7)(7)106(5)(1)(3)
Interest expense–––––0––––
Other non-operating income (expense)(0)0(1)(4)(0)(1)(0)(0)(1)0
Income before taxes–––––96(5)(2)(3)
Income tax expense–––00002765
Net income from continuing operations(9)(7)(8)(11)–95(32)(8)(8)
Net income(9)(13)(8)(11)(7)95(32)(8)(8)
Net income to common shareholders––(9)(13)(10)95(32)(8)(8)